BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7169515)

  • 1. Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.
    Nissim M; Ambrosi B; Bernasconi V; Giannattasio G; Giovanelli MA; Bassetti M; Vaccari U; Moriondo P; Spada A; Travaglini P; Faglia G
    J Endocrinol Invest; 1982; 5(6):409-15. PubMed ID: 7169515
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bromocriptine for prolactin-secreting macroadenomas of the pituitary].
    Landman L; Spindel A; Tal Y; Bar-Meir A; Sharf M; Dickstein G
    Harefuah; 1987 Oct; 113(7-8):156-9. PubMed ID: 3428740
    [No Abstract]   [Full Text] [Related]  

  • 3. [Micro- and macroprolactinomas and their treatment with bromocriptine (parlodel)].
    von Werder K
    Akush Ginekol (Mosk); 1984 May; (5):11-4. PubMed ID: 6465439
    [No Abstract]   [Full Text] [Related]  

  • 4. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.
    Tindall GT; Kovacs K; Horvath E; Thorner MO
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1178-83. PubMed ID: 6752167
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
    N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM; Bevan JS; Burke CW; Adams CB
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G; Cardone A; Marafioti F; Alvino N
    Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
    Guibout M; Jaquet P; Grisoli F; Tapias PL; Mouly A
    Ann Med Interne (Paris); 1982; 133(1):48-50. PubMed ID: 7065589
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of postoperative bromocriptine treatment for prolactin-secreting pituitary adenomas].
    Sato O; Niwa J; Inoue Y; Akagawa S; Kobayashi K
    No Shinkei Geka; 1983 Jan; 11(1):51-60. PubMed ID: 6682184
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prolactin adenoma with ophthalmological manifestations. Treatment with bromocriptine].
    Saraux H; Offret H; Brasnu C; Charpentier G
    Bull Soc Ophtalmol Fr; 1980; 80(6-7):489-93. PubMed ID: 7408092
    [No Abstract]   [Full Text] [Related]  

  • 13. [Regression with purely medical treatment of pituitary prolactin adenomas].
    Bricaire H
    Ann Med Interne (Paris); 1982; 133(1):58. PubMed ID: 7065591
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine treatment of prolactinomas.
    von Werder K; Eversmann T; Fahlbusch R; Rjosk HK
    N Engl J Med; 1979 Jun; 300(24):1391-2. PubMed ID: 440368
    [No Abstract]   [Full Text] [Related]  

  • 15. Bromocriptine treatment of prolactinomas.
    Bergh T; Nillius SJ; Lundberg PO; Wide L
    N Engl J Med; 1979 Jun; 300(24):1391. PubMed ID: 440367
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine treatment of prolactinomas.
    McGregor AM; Hall K; Scanlon MF; Hall R
    N Engl J Med; 1979 Jun; 300(24):1392. PubMed ID: 440369
    [No Abstract]   [Full Text] [Related]  

  • 18. Bromocriptine treatment of prolactinomas.
    Aronoff SL; Daughaday WH; Laws ER
    N Engl J Med; 1979 Jun; 300(24):1391. PubMed ID: 440366
    [No Abstract]   [Full Text] [Related]  

  • 19. Short-term preoperative treatment of macroprolactinomas by dopamine agonists.
    Fahlbusch R; Buchfelder M; Schrell U
    J Neurosurg; 1987 Dec; 67(6):807-15. PubMed ID: 3681420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.
    Schettini G; Lombardi G; Merola B; Miletto P; Fariello C; Cirillo S; Fusco R; Lancranjan I
    J Endocrinol Invest; 1988 Jan; 11(1):47-51. PubMed ID: 3361075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.